Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,287 public trials 1,279 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

NCT03598244

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +25 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

NCT03363373

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Hospital for Sick Children Toronto, Canada
  • Rigshospitalet Copenhagen, Denmark
View all 20 locations
View Trial Details
Active, Not Recruiting

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NCT03180502

Conditions
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Emory Proton Therapy Center Atlanta, Georgia, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

NCT05415072

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Memorial Sloane Ketterin Cancer Ctr New York, United States
  • Novartis Investigative Site Westmead, New South Wales, Australia
View Trial Details
Active, Not Recruiting

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

NCT01362803

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +22 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions